Gregory Y.H. Lip-rekin lankidetzan egindako argitalpenak (21)

2023

  1. Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea

    FASEB Journal, Vol. 37, Núm. 6

2019

  1. Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease

    Scientific Reports, Vol. 9, Núm. 1

2017

  1. Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

    Scientific Reports, Vol. 7

2016

  1. Long-term predictors of thromboembolic events in nonvalvular atrial fibrillation patients undergoing electrical cardioversion

    Circulation Journal, Vol. 80, Núm. 3, pp. 605-612

2015

  1. Effects of body mass index on the lipid profile and biomarkers of inflammation and a fibrinolytic and Prothrombotic state

    Journal of Atherosclerosis and Thrombosis, Vol. 22, Núm. 6, pp. 610-617

2014

  1. Biomarkers in atrial fibrillation: An overview

    International Journal of Clinical Practice, Vol. 68, Núm. 4, pp. 434-443

  2. High-sensitivity troponin t as a biomarker for the development of atrial fibrillation after cardiac surgery

    European Journal of Cardio-thoracic Surgery, Vol. 45, Núm. 4, pp. 733-738

  3. Prognostic value of two polymorphisms in non-sarcomeric genes for the development of atrial fibrillation in patients with hypertrophic cardiomyopathy

    QJM, Vol. 107, Núm. 8, pp. 613-621

  4. Small-size platelet microparticles trigger platelet and monocyte functionality and modulate thrombogenesis via P-selectin

    British Journal of Haematology, Vol. 166, Núm. 4, pp. 571-580

2013

  1. Interleucina 6 y proteína C reactiva ultrasensible para la predicción de la evolución clínica en síndromes coronarios agudos sin elevación del segmento ST

    Revista Espanola de Cardiologia, Vol. 66, Núm. 3, pp. 185-192

  2. Small-size circulating microparticles in acute coronary syndromes: Relevance to fibrinolytic status, reparative markers and outcomes

    Atherosclerosis, Vol. 227, Núm. 2, pp. 313-322

  3. The prognostic role of the adiponectin levels in atrial fibrillation

    European Journal of Clinical Investigation, Vol. 43, Núm. 2, pp. 168-173

2012

  1. Subclinical atherosclerotic endothelial damage as predictor for bleeding in anticoagulated atrial fibrillation patients

    Journal of Internal Medicine

  2. Valor predictivo de la escala CHA 2DS 2-VASc en pacientes con fibrilación auricular de alto riesgo embólico en tratamiento anticoagulante

    Revista Espanola de Cardiologia, Vol. 65, Núm. 7, pp. 627-633

2011

  1. Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy

    JRAAS - Journal of the Renin-Angiotensin-Aldosterone System, Vol. 12, Núm. 4, pp. 521-530

  2. Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: A pilot study

    Thrombosis Research

  3. Interactions between clopidogrel and proton pump inhibitors: A review of evidence

    Current Medicinal Chemistry, Vol. 18, Núm. 16, pp. 2386-2400

  4. Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients

    Journal of the American College of Cardiology, Vol. 57, Núm. 25, pp. 2496-2504

2010

  1. Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction

    Thrombosis and Haemostasis

2009

  1. Biomarkers of pathophysiology in hypertrophic cardiomyopathy: Implications for clinical management and prognosis

    European Heart Journal, Vol. 30, Núm. 2, pp. 139-151